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Abstract
Purpose of Review Functional movement disorders are common and disabling causes of abnormal movement control. Here, we
review the current state of the evidence on the use of neuroimaging in Functional movement disorders, particularly its role in
helping to unravel the pathophysiology of this enigmatic condition.
Recent Findings In recent years, there has been a shift in thinking about functional movement disorder, away from a focus
on high-level psychological precipitants as in Freudian conversion theories, or even an implicit belief they are ‘put-on’ for
secondary gain. New research has emphasised novel neurobiological models incorporating emotional processing, self-
representation and agency.
Summary Neuroimaging has provided new insights into functional movement disorders, supporting emerging neurobio-
logical theories implicating dysfunctional emotional processing, self-image and sense of agency. Recent studies have also
found subtle structural brain changes in patients with functional disorders, arguing against a strict functional/structural
dichotomy.
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Introduction
Functional neurological disorders (FND) are common, ac-
counting for 16% of all referrals to general neurology clinics
but have historically been rather neglected in research and clin-
ical service development [1]. Research and clinical work with
people with functional movement disorders (FMDs) has helped
to lead a shift in thinking about FND by emphasising positive
diagnostic criteria, and by development of neurobiological-
level theories of the pathophysiology of FND. Neuroimaging
has formed a key part of this work, providing data that has
informed pathophysiological understanding.
A wide variety of terms have been used to describe FNDs
including ‘hysterical’, ‘conversion’ and ‘somatisation’, each
with implications about the underlying mechanism.
‘Functional neurological symptoms’ is now used as a neutral
umbrella term for all ‘non-organic’ symptoms which is non-
judgemental and acceptable to patients. This has helped to
create a shift in thinking about FNDs, away from a focus on
high-level psychological precipitants as in Freudian conver-
sion theories, or even an implicit belief they are ‘put-on’ for
secondary gain. New research has emphasised novel neurobi-
ological models incorporating emotional processing, self-
representation and agency [2]. Advances in neuroimaging
have provided new insights into changes in brain activity,
functional connectivity and brain structure in FND. The diag-
nosis of FND is based on identifying clinical signs which are
inconsistent with organic disease, and which may vary over
time or with attention [3]. As functional movement disorders
(FMDs) can be assessed objectively with physical examina-
tion in a clinic setting, changes over time and the effects of
attention can be clearly documented. This makes them an
ideal model to investigate the underlying mechanism of
FNDs in general.
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Using Neuroimaging to Exclude Co-Morbid
Organic Disease
In all patients who present with a new neurological symptom,
the first concern is to exclude conditions requiring urgent
treatment. In FND, the clinical history and examination is
often clear enough to do this. If there is any uncertainty, espe-
cially as organic and functional symptomsmay co-exist, struc-
tural neuroimaging such as CT and MRI can be used to ex-
clude a co-morbid organic disorder in specific circumstances.
This is particularly important where multiple disease pro-
cesses produce a mixed clinical picture, or where an underly-
ing organic process is associated functional ‘overlay’.
Functional symptoms may be triggered by a ‘stressor’ which
can be physical, such as limb injury, psychological or both [4].
Elmalı and colleagues recorded the case of a patient with a
functional tremor, but imaging abnormalities prompted further
investigation, which revealed the presence ofWilson’s disease
[5]. Kwon and colleagues used structural imaging to diagnose
a rare subtype of motor neurone disease in a patient with a
functional tremor [6]. In both these cases, the implication is
not that the original diagnosis of a functional movement dis-
order was incorrect, but that functional symptoms can co-
occur with other illnesses, some of which may be treatable
in their own right.
In certain patients, specific imaging techniques can provide
greater diagnostic certainty—an example is idiopathic
Parkinson’s disease and functional parkinsonism. Functional
overlay appears to be commoner than expected in patients
with idiopathic Parkinson’s disease while pure functional par-
kinsonism seems comparatively rare [7, 8]. The fact that idi-
opathic Parkinson’s disease has effective treatment options
makes the distinction important.
Dopamine transporter-single-photon emission computer
tomography (DaTSCAN) uses a radioactive ligand which
binds to dopamine transporters and is highly sensitive to the
pattern of nigrostriatal denervation characteristic of idiopathic
Parkinson’s disease [9, 10]. DaTSCANs are normal in func-
tional or drug-induced parkinsonism, making it a highly effec-
tive tool in certain cases [11, 12]. Other techniques such as
[123I]-FP-CIT SPECT, which also uses a radiolabelled ligand,
can add further accuracy, especially between idiopathic and
drug-induced parkinsonism [13]. Umeh and colleagues inves-
tigated three patients with a mixed clinical picture of function-
al and neurodegenerative parkinsonism. Two patients had ab-
normal DaTSCANs and were diagnosed with idiopathic
Parkinson’s disease with co-morbid functional symptoms,
while the third patient had normal imaging leading to a diag-
nosis of functional parkinsonism [14]. Gaig and colleagues
used [123I]-Ioflupane SPECT imaging in nine patients with
suspected functional parkinsonism. The results were normal
in 8 patients, but one had bilaterally decreased tracer uptake,
and further investigation led to the identification of a parkin
gene mutation [15]. These studies show how targeted imaging
can aid diagnosis, even in complex or overlap cases.
Functional Imaging and Novel
Neurobiological Models of FMDs
Recent neuroimaging studies have implicated abnormal emo-
tional processing, sense of agency, and top-down regulation
from frontal areas as important pathophysiological compo-
nents in FMD [16]. Functional imaging techniques such as
fMRI and PET allow abnormalities in regional brain activa-
tion, and functional connectivity between brain areas, to be
measured. In the future, these differences could potentially be
used to aid the diagnosis of FMDs. Wergrzyk and colleagues
used resting state fMRI to distinguish FMD from matched
controls with over 68% sensitivity and specificity [17]. This
was primarily using connectivity around the right caudate,
amygdala, prefrontal and sensorimotor regions which were
hyperconnected in FMD [17].
Abnormal Emotional Processing
There has been considerable interest in how traumatic experi-
ences and emotional factors might be involved in the patho-
genesis of FMD. Voon and colleagues found that patients with
functional weakness showed reduced activity in the left sup-
plementary motor area (SMA), which is involved in move-
ment initiation, when performing movement tasks [16]. They
also had increased activity in the right amygdala, insula and
bilateral posterior cingulate cortices, which are involved in
emotional processing. There was reduced functional connec-
tivity between the left SMA and the bilateral dorsolateral pre-
frontal cortices when performing internally generated com-
pared to externally generated movements. The authors pro-
posed that in ‘emotionally arousing’ contexts, abnormal
learned motor patterns interfere with normal movement initi-
ation in the SMA, which is hypoactive and has reduced con-
nection to the frontal lobe [16].
Increased activity in the amygdala, insula and cingulate
cortices may indicate FMD patients have greater involvement
of emotional processing areas inmovement. In 1997,Marshall
and colleagues recorded regional cerebral blood flow (rCBF)
of a patient with unilateral functional leg weakness [18]. She
had normal activation while moving her good leg and while
preparing to move her weak leg, but when attempting to move
her weak leg there was no activation of the primary motor
cortex. Instead, the orbitofrontal and anterior cingulate corti-
ces activated, which are involved in emotional processing and
particularly previous traumatic emotional experiences [18]. It
was suggested these areas inhibited activation of the primary
motor cortex, preventing movement [18].
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A further study by Voon and colleagues in 2010 found that
patients with functional weakness showed less difference in
activation of the right amygdala on exposure to fearful or
happy faces than healthy controls [19]. These patients also
had a tendency towards greater activation of the right amyg-
dala than controls, suggesting increased excitability and de-
creased habituation [19]. There was also greater functional
connectivity between the right amygdala and the right SMA
in functional patients than controls [19]. This could imply
changes in emotional processing and greater emotional in-
volvement in movement initiation.
In 2018, Espay and colleagues investigated emotional pro-
cessing in patients with functional tremor, comparing them
with patients with essential tremor and controls in finger tap-
ping, basic-emotion and intense-emotion tasks [20•].
Functional patients showed increased activation of the cere-
bellum in the motor task compared to those with essential
tremor [20•]. In the basic-emotion task, functional patients
had increased activation of the paracingulate and left
Heschl’s gyrus compared to controls, but decreased activation
of the right precentral gyrus compared to essential tremor
patients. Again, patients with functional symptoms showed
changes in areas involved in emotional processing. The study
was repeated using patients with functional and primary or-
ganic dystonia [21]. Patients with functional dystonia had al-
tered activation during the basic and intense emotion tasks in
several areas, including decreased activation of the left insular
and motor cortices [21]. In 2018, LaFaver and colleagues
published a study comparing fMRI of 9 FMD patients pre-
and postrehabilitation [22••]. They found a significant shift in
activation during a Go/No-Go task from the visual cortex,
cerebellar vermis and hippocampus to caudate, putamen and
SMA, indicating a shift from bottom-up to top-down control
of motor function [22••]. Interestingly, they found that im-
proved outcome was related to increased functional connec-
tivity posttreatment between primary motor cortex and the
amygdala [22••].
These studies support the link between emotional process-
ing and FMDs by showing altered activation of brain areas
involved in emotional processing and increased functional
connectivity between emotional and movement-related brain
areas. This could provide a mechanism for emotional dysreg-
ulation to interfere with movement.
Abnormal Sense of Agency
Functional motor symptoms show some features of voluntary
movement, such as distractibility and variability with atten-
tion. Despite this, patients perceive their movements, or lack
of movement, as involuntary. This suggests that part of the
pathology of FMDs may be related to a patient’s sense of
agency. ‘Agency’ is the experience of being the cause of our
own actions [23, 24] and while it is linked to intention, there is
evidence it is a ‘post-intention’ process. The sense of agency
is a process of retrospective assessment of the action and the
expected and actual sensory consequences [25]. This depends
on the comparison of actual sensory feedback with the pre-
dicted sensory signal, known as ‘efference copy’ [26, 27].
This process has been localised to the temporo-parietal junc-
tion (TPJ), prefrontal cortices and the cerebellum [28, 29].
Advances in functional imaging allow us to investigate this
feature of FMD and identify the brain regions involved. One
benefit is to show conclusive differences between the neuro-
imaging correlates of functional weakness and a subject inten-
tionally feigning weakness.
Voon and colleagues found reduced activation of the right
temporo-parietal junction (TPJ) and reduced connectivity be-
tween it and the sensorimotor cortex and cerebellum in pa-
tients with functional tremor compared to voluntarily mim-
icked tremor in the same patients [28]. Another study in
2016 compared the functional connectivity of the right TPJ
at rest in FMD patients with controls [30]. It found decreased
connectivity with bilateral sensorimotor areas, the cerebellum,
the SMA and the right insula, supporting impaired sensorimo-
tor feedback integration. Nahab and colleagues published a
study comparing fMRI findings of FMD patients with controls
during a virtual reality movement task designed to modulate
sense of agency [31, 32]. FMD patients showed dorsolateral
prefrontal cortex and presupplementary motor area dysfunc-
tion which was unaffected by the loss of movement control
[32].
Baek and colleagues used the Libet’s Clock task to assess
FND patients’ accuracy in measuring their agency over the
movement of a dot on the screen [33]. Compared to healthy
controls, they had reduced activity of the inferior parietal lob-
ule of the right TPJ when comparing movement verses inten-
tion trials. They also found a reduction in rest-state connectiv-
ity between the right TPJ and the dorsolateral prefrontal and
anterior cingulate cortices, with increased connectivity with
the premotor cortex and SMA. Reduced activity in areas in-
volved in integrating sensory feedback after movement in
functional patients supports a role for dysfunctional sense of
agency in these symptoms.
Van Beilen and colleagues reported decreased activity in
the supramarginal gyrus in FND patients [34], thought to be
involved in integration of somatic and environmental cues
leading to impaired movement initiation. Activity in the
precuneus, which is also linked to sense of agency, was re-
duced in functional patients and importantly, was increased in
feigning controls [34]. Feigning controls also had increased
activity in the presupplementary motor area, which has been
linked to motor intention [25, 34]. Hassa and colleagues in
2016 investigated motor inhibition specifically—comparing
patients with functional motor weakness with controls
feigning weakness [35••]. Passive movement of the weak
hand activated the inferior frontal gyrus, but in different areas
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in functional and feigning controls. They also observed in-
creased activity in the medial prefrontal cortex in the function-
al patients, which may also represent dysfunctional sense of
agency [35••].
Another study compared patients with functional tremor,
essential tremor and controls during a tremor-inducing motor
task and at rest [36]. During the motor task, patients with
functional tremor showed reduced rCBF in anterior regions
of the default mode network, but at rest had increased rCBF in
the inferior frontal gyrus and left insula. The authors related
the differences to abnormalities in the default mode network in
functional patients. The default mode network, also known as
the task-negative network, is a set of brain regions noted to be
active together when a person is wakeful but at rest. It is
thought to be involved in thinking about the self, forward
planning and theory of mind. This supports functional symp-
toms arising from abnormalities in self-representation and
agency [36].
These results highlight the difference between patients
feigning weakness and those with functional symptoms.
They demonstrate differences in the activation and connectiv-
ity of a network, including the right TPJ and precuneus, which
is believed to integrate sensory and motor feedback to gener-
ate a sense of agency.
Abnormal Inhibitory Activity in Functional Weakness
Burgmer and colleagues analysed fMRI activity during obser-
vation and imitation tasks in patients with functional hand
weakness [37]. They found reduced activation of cortical
areas related to hand movement compared to controls when
observing movement, but no evidence of frontal lobe move-
ment inhibition [37]. This was felt to demonstrate impairment
of movement conceptualisation rather than active inhibition
from the frontal lobe. Cojen and colleagues compared fMRI
activity on a Go/No-Go task in one patient with left-sided
functional weakness with controls feigning weakness [38].
There was preserved right motor cortex preparatory activa-
tion, suggesting preserved intention. During inability to move
the affected left hand in Go trials, there was increased activity
of the precuneus and ventrolateral frontal gyrus, and increased
functional connectivity between the posterior cingulate,
precuneus and ventromedial prefrontal cortex [38]. During
No-Go trials, there was normal inhibitory frontal activation
in the right hand but none for the weak left hand. In con-
trast, for the feigning weakness controls, there were similar
patterns of activity for No-Go and Go trials with the
feigned weak hand. The authors argued this showed that
functional weakness was not the direct result of frontal
inhibition, as in the voluntary decision to not go, but due
to activation of midline structures related to self-presenta-
tion, agency and emotional regulation.
Spence and colleagues used PET imaging to show that
attempted movement of a functionally weak hand was associ-
ated with hypoactivation of the left dorsolateral prefrontal cor-
tex, while attempted movement of a feigned weak hand was
associated with hypoactivation of the right anterior prefrontal
cortex [39]. They argued this linked motor inhibition in func-
tional weakness to the prefrontal cortex [39].
Role of Subcortical Structures in Functional
Neurological Disorders
There has been comparatively little research looking at the
involvement of subcortical structures in functional movement
disorders. Vuilleumier and colleagues used SPECT scanning
to investigate patients with functional unilateral sensorimotor
impairment during hand vibratory stimulation and found de-
creased activation of the contralateral thalamus and basal gan-
glia [40].When this was repeated after symptom improvement
activation had normalised, suggesting the abnormality was
related to the generation of symptoms, rather than a trait phe-
nomenon [40].
Schrag and colleagues used PET to compare functional and
organic dystonia patients at rest, during fixed posturing and
paced movements [41]. Both forms of dystonia showed in-
creased activation of the right dorsolateral prefrontal cortex
during movement compared to controls, suggesting prefrontal
cortex activation is non-specific. Patients with functional dys-
tonia showed greater activation in the cerebellum and basal
ganglia compared to patients with organic dystonia, who
showed greater activation in the primary motor cortex.
Structural Changes in Functional Movement
Disorders
Considerable efforts have been made to promote the use of the
word “functional” in recent times, but emerging imaging ev-
idence suggests that replacing one dualistic simplification
(physical vs. psychological) with another (functional vs. struc-
tural) is not without its problems. New studies have highlight-
ed structural changes in the brains of patients with FMDs.
Morphometric MRI techniques have detected subtle changes
in volume and cortical thickness, particularly in areas thought
to be involved in stress-related neuroplasticity [42, 43•, 44].
Both FMD and psychological conditions such as posttrau-
matic stress disorder (PTSD) have been associated with
changes in areas responsible for emotional processing, such
as the insula, cingulate cortex and amygdala [42]. These areas
are believed to be subject to stress-mediated neuroplasticity,
which may provide a mechanism for the changes in their ac-
tivity and, over time, structure. Perez and colleagues measured
the volume of the left insula cortex in women with FND. In
one subgroup, there was a correlation of lower volumes with
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increasing symptom severity and childhood abuse burden
[42]. In patients with PTSD symptom, severity was associated
with lower volumes of the dorsal anterior cingulate cortex, and
lifetime adverse event magnitude was inversely correlated
with left hippocampal volumes [42]. Another study from
Perez and colleagues used post hoc stratified analysis to show
that physical impairment in FND patients was inversely cor-
related with left anterior insula volume compared to controls
[43•]. Further, within group analysis of FND patients showed
a correlation between mental health impairment, increased
trait anxiety and increased right amygdala volumes [43•]. In
a subsequent study published, Perez and colleagues found that
FMD patients with high somatoform dissociation scores had
reduced left anterior cingulate cortex thickness compared to
controls [44]. They also reported a positive correlation be-
tween scores for depersonalisation/derealisation and right lat-
eral occipital thickness [44]. Williams and colleagues showed
that in FMD patients, changes in the hippocampal cortical
thickness and volume were associated with differences in
self-reported attachment styles [45].
Aybek and colleagues usedMRI voxel based cortical thick-
ness analysis (VBCT) to show significantly increased thick-
ness in the premotor cortex of patients with functional
hemiparesis compared to controls [46]. Another study by
Nicholson found significant reduction in left thalamus vol-
ume in patients with FMD when compared to controls,
which did not vary with laterality, severity of symptoms
or handedness [47]. Sarasso and colleagues showed that
compared to healthy controls, functional dystonia patients
had reduced volume of the right thalamus and bilateral
caudate with bilateral thinning of the precentral and
frontoparietal cortices [48]. This is in addition to reduced
functional connectivity between the right basal ganglia,
dorsolateral prefrontal cortex and precuneus [48].
There is a growing body of evidence to suggest that subtle
changes in brain area volume and cortical thickness may occur
in functional neurological disorders. These may be secondary
changes due to limb disuse in the case of thalamic or motor
areas, but the changes in cingulo-insular structures more likely
reflects stress-mediated neuroplasticity. This provides further
evidence linking abnormal emotional processing to the neu-
robiology of FMDs.
Conclusions
Functional neurological disorders are an exciting and rapidly
expanding field of research within neuroscience. Functional
movement disorders are especially amenable to investigation
due to the nature of the symptoms and the comparative ease of
constructing experimental paradigms, and this has placed
them at the forefront of research. Neuroimaging has for a long
time been a part of diagnosis of functional movement
disorders primarily for assisting in the diagnosis of co-
morbid organic disorders. More targeted forms of imaging,
such as DaTSCANs are additionally useful in specific
circumstances.
More recent developments in functional imaging have pro-
vided many new insights into the brain networks involved, as
well as providing some supportive evidence for pathophysio-
logical theories. Most recently, volumetric analysis has detect-
ed possible structural changes in the brains of FND patients.
Caution is needed, because as with all research in people
with FMD, the patients themselves are very heterogenous in
terms of symptoms and co-morbidities, with a high incidence
of psychiatric co-morbidities and potentially relevant early life
or more recent stressors. So far imaging research in FMD has
used diverse paradigms, patient types and relatively small
numbers for each study. It is also important that functional
imaging can only give correlations, and these are vulnerable
to confounding factors. Nevertheless, there is converging ev-
idence about the underlying neurobiology of functional move-
ment disorders and neuroimaging will continue to play a key
role as the field develops.
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